C22orf39 Antibody
Novus Biologicals, part of Bio-Techne | Catalog # NBP2-58003
Key Product Details
Species Reactivity
Human
Applications
Immunocytochemistry/ Immunofluorescence
Label
Unconjugated
Antibody Source
Polyclonal Rabbit IgG
Concentration
Concentrations vary lot to lot. See vial label for concentration. If unlisted please contact technical services.
Product Specifications
Immunogen
This antibody was developed against a recombinant protein corresponding to the following amino acid sequence: AEAQQSLCESERARVRAARKHILVWAPRQSPPPDWHLPLPQEKDE
Clonality
Polyclonal
Host
Rabbit
Isotype
IgG
Scientific Data Images for C22orf39 Antibody
Immunocytochemistry/ Immunofluorescence: C22orf39 Antibody [NBP2-58003]
Immunocytochemistry/Immunofluorescence: C22orf39 Antibody [NBP2-58003] - Staining of human cell line Hep G2 shows localization to endoplasmic reticulum.Applications for C22orf39 Antibody
Application
Recommended Usage
Immunocytochemistry/ Immunofluorescence
0.25-2 ug/ml
Application Notes
Immunocytochemistry/Immunofluorescence Fixation Permeabilization: Use PFA/Triton X-100.
Formulation, Preparation, and Storage
Purification
Affinity purified
Formulation
PBS (pH 7.2) and 40% Glycerol
Preservative
0.02% Sodium Azide
Concentration
Concentrations vary lot to lot. See vial label for concentration. If unlisted please contact technical services.
Shipping
The product is shipped with polar packs. Upon receipt, store it immediately at the temperature recommended below.
Stability & Storage
Store at 4C short term. Aliquot and store at -20C long term. Avoid freeze-thaw cycles.
Background: C22orf39
Alternate Names
chromosome 22 open reading frame 39, DKFZp686I08210, hypothetical protein LOC128977, MGC74441
Gene Symbol
C22ORF39
Additional C22orf39 Products
Product Documents for C22orf39 Antibody
Product Specific Notices for C22orf39 Antibody
This product is for research use only and is not approved for use in humans or in clinical diagnosis. Primary Antibodies are guaranteed for 1 year from date of receipt.
Loading...
Loading...
Loading...
Loading...